annual cash & cash equivalents:
$299.72M+$194.65M(+185.25%)Summary
- As of today (September 17, 2025), LMAT annual cash & cash equivalents is $299.72 million, with the most recent change of +$194.65 million (+185.25%) on December 31, 2024.
- During the last 3 years, LMAT annual cash & cash equivalents has risen by +$229.76 million (+328.43%).
- LMAT annual cash & cash equivalents is now at all-time high.
Performance
LMAT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$319.49M+$16.94M(+5.60%)Summary
- As of today (September 17, 2025), LMAT quarterly cash & cash equivalents is $319.49 million, with the most recent change of +$16.94 million (+5.60%) on June 30, 2025.
- Over the past year, LMAT quarterly cash & cash equivalents has increased by +$206.39 million (+182.49%).
- LMAT quarterly cash & cash equivalents is now at all-time high.
Performance
LMAT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LMAT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +185.3% | +182.5% |
| 3 y3 years | +328.4% | +322.1% |
| 5 y5 years | +817.1% | +1175.4% |
LMAT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +328.4% | at high | +322.1% |
| 5 y | 5-year | at high | +1011.0% | at high | +1368.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
LMAT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $319.49M(+5.6%) |
| Mar 2025 | - | $302.55M(+0.9%) |
| Dec 2024 | $299.72M(+185.2%) | $299.72M(+141.9%) |
| Sep 2024 | - | $123.89M(+9.5%) |
| Jun 2024 | - | $113.10M(+4.4%) |
| Mar 2024 | - | $108.29M(+3.1%) |
| Dec 2023 | $105.07M(+27.1%) | $105.07M(+8.3%) |
| Sep 2023 | - | $97.02M(+7.6%) |
| Jun 2023 | - | $90.18M(+11.3%) |
| Mar 2023 | - | $81.00M(-2.0%) |
| Dec 2022 | $82.69M(+18.2%) | $82.69M(+3.7%) |
| Sep 2022 | - | $79.74M(+5.4%) |
| Jun 2022 | - | $75.68M(+6.8%) |
| Mar 2022 | - | $70.88M(+1.3%) |
| Dec 2021 | $69.96M(+159.3%) | $69.96M(+4.3%) |
| Sep 2021 | - | $67.08M(+208.3%) |
| Jun 2021 | - | $21.76M(-8.4%) |
| Mar 2021 | - | $23.74M(-12.0%) |
| Dec 2020 | $26.98M(-17.5%) | $26.98M(-21.5%) |
| Sep 2020 | - | $34.38M(+37.2%) |
| Jun 2020 | - | $25.05M(-18.2%) |
| Mar 2020 | - | $30.63M(-6.3%) |
| Dec 2019 | $32.68M(-31.9%) | $32.68M(-27.2%) |
| Sep 2019 | - | $44.90M(-6.9%) |
| Jun 2019 | - | $48.24M(+1.7%) |
| Mar 2019 | - | $47.46M(-1.1%) |
| Dec 2018 | $47.99M(+15.2%) | $47.99M(+5.2%) |
| Sep 2018 | - | $45.63M(-13.8%) |
| Jun 2018 | - | $52.94M(+16.6%) |
| Mar 2018 | - | $45.39M(+9.0%) |
| Dec 2017 | $41.66M(+71.5%) | $41.66M(+11.1%) |
| Sep 2017 | - | $37.51M(+24.5%) |
| Jun 2017 | - | $30.12M(+16.7%) |
| Mar 2017 | - | $25.81M(+6.3%) |
| Dec 2016 | $24.29M(-11.5%) | $24.29M(-29.9%) |
| Sep 2016 | - | $34.65M(+18.2%) |
| Jun 2016 | - | $29.32M(+13.0%) |
| Mar 2016 | - | $25.94M(-5.5%) |
| Dec 2015 | $27.45M | $27.45M(+16.2%) |
| Sep 2015 | - | $23.63M(+21.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $19.43M(+14.1%) |
| Mar 2015 | - | $17.02M(-8.9%) |
| Dec 2014 | $18.69M(+27.1%) | $18.69M(+1.8%) |
| Sep 2014 | - | $18.35M(-21.9%) |
| Jun 2014 | - | $23.51M(+88.0%) |
| Mar 2014 | - | $12.50M(-15.0%) |
| Dec 2013 | $14.71M(-10.6%) | $14.71M(+8.0%) |
| Sep 2013 | - | $13.63M(-8.6%) |
| Jun 2013 | - | $14.91M(-2.6%) |
| Mar 2013 | - | $15.30M(-7.0%) |
| Dec 2012 | $16.45M(-18.3%) | $16.45M(-20.3%) |
| Sep 2012 | - | $20.64M(+2.4%) |
| Jun 2012 | - | $20.16M(+2.8%) |
| Mar 2012 | - | $19.62M(-2.5%) |
| Dec 2011 | $20.13M(-11.0%) | $20.13M(-12.8%) |
| Sep 2011 | - | $23.09M(+7.9%) |
| Jun 2011 | - | $21.41M(+12.1%) |
| Mar 2011 | - | $19.10M(-15.5%) |
| Dec 2010 | $22.61M(-5.8%) | $22.61M(-18.1%) |
| Sep 2010 | - | $27.62M(+6.4%) |
| Jun 2010 | - | $25.95M(+7.7%) |
| Mar 2010 | - | $24.10M(+0.4%) |
| Dec 2009 | $24.00M(+12.9%) | $24.00M(+5.6%) |
| Sep 2009 | - | $22.73M(+14.7%) |
| Jun 2009 | - | $19.82M(+14.8%) |
| Mar 2009 | - | $17.26M(-18.8%) |
| Dec 2008 | $21.25M(-7.1%) | $21.25M(+10.9%) |
| Sep 2008 | - | $19.16M(+4.9%) |
| Jun 2008 | - | $18.27M(-20.2%) |
| Dec 2007 | $22.89M(-25.7%) | $22.89M(-10.7%) |
| Sep 2007 | - | $25.64M(-8.2%) |
| Jun 2007 | - | $27.93M(-2.4%) |
| Mar 2007 | - | $28.62M(-7.1%) |
| Dec 2006 | $30.81M(-8.0%) | $30.81M(+6700.9%) |
| Sep 2006 | - | $453.00K(-32.0%) |
| Jun 2006 | - | $666.00K(+42.0%) |
| Mar 2006 | - | $469.00K(-98.6%) |
| Dec 2005 | $33.51M(+3172.0%) | $33.51M(+4527.8%) |
| Dec 2004 | $1.02M(+83.2%) | $724.00K |
| Dec 2003 | $559.00K(+65.9%) | - |
| Dec 2002 | $337.00K | - |
FAQ
- What is LeMaitre Vascular, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for LeMaitre Vascular, Inc.?
- What is LeMaitre Vascular, Inc. annual cash & cash equivalents year-on-year change?
- What is LeMaitre Vascular, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for LeMaitre Vascular, Inc.?
- What is LeMaitre Vascular, Inc. quarterly cash & cash equivalents year-on-year change?
What is LeMaitre Vascular, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of LMAT is $299.72M
What is the all time high annual cash & cash equivalents for LeMaitre Vascular, Inc.?
LeMaitre Vascular, Inc. all-time high annual cash & cash equivalents is $299.72M
What is LeMaitre Vascular, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, LMAT annual cash & cash equivalents has changed by +$194.65M (+185.25%)
What is LeMaitre Vascular, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of LMAT is $319.49M
What is the all time high quarterly cash & cash equivalents for LeMaitre Vascular, Inc.?
LeMaitre Vascular, Inc. all-time high quarterly cash & cash equivalents is $319.49M
What is LeMaitre Vascular, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, LMAT quarterly cash & cash equivalents has changed by +$206.39M (+182.49%)